The Medicines and Healthcare products Regulatory Agency said it will adopt all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, shifting UK policy toward continuous oversight of machine-learning devices instead of one-time approvals that assume software never changes. The commitment includes draft guidance by December on managing post-market updates, early-2027 consultations on classification, and a spring 2027 roadmap—plus a new AI Airlock sandbox cohort focused on lifecycle surveillance.
Why static approvals fall short
Commission clinicians argued that AI-enabled diagnostics can drift as hospitals retrain models on local data or vendors push silent patches. A cleared chest X-ray algorithm might perform differently in a district general hospital than in the teaching centre where it was validated. Continuous monitoring, they said, is the only way to maintain safety without banning adaptive tools outright.
MHRA leaders echoed that static pathways were built for metal implants, not neural networks that learn from weekly scans.
Timeline and Airlock
Regulators will publish draft change-control rules in December, explaining when manufacturers must file substantial amendments versus minor bug fixes. A consultation on qualifying AI as medium- or high-risk devices opens early next year. The full roadmap due by spring 2027 will map each commission recommendation to a policy owner.
Separately, MHRA opened applications for the latest AI Airlock cohort, prioritising post-market surveillance prototypes. First selections are expected in November, giving startups a supervised path to test monitoring tools without immediate full market authorisation.
Industry reaction
Health-tech firms welcomed clarity but warned that dual UK-EU pathways could raise costs if Brussels diverges. Hospital procurement teams want standardised audit logs before they renew imaging contracts. Patient groups asked for plain-language notices when software versions change mid-treatment.
For NHS trusts already deploying triage chatbots and radiology assistants, the message is that procurement must budget for monitoring staff, not just licence fees.
Commission origins
The NHS-led commission included frontline radiologists, anaesthetists and patient advocates who reviewed incidents where locked algorithms failed on new scanner hardware. Their report argued that post-market surveillance should be mandatory, not voluntary industry goodwill.
Comparison with EU pathways
With the UK retaining its own device framework after Brexit, manufacturers face potential duplication if EU AI Act documentation diverges. Trade associations asked MHRA for mutual recognition talks; regulators said they will align on principles while keeping sovereignty over enforcement.
Trust procurement
Hospital buyers are rewriting tenders to require software bills of materials and update logs. Lawyers said liability for model drift may shift toward vendors who promise continuous monitoring but fail to file change notices.